11 March 2008

Just When You Think that Drug Companies Can't Get Any More Contemptible

Pfizer is going to court to try and force the New England Journal of Medicine (NEJM) to reveal the names of its anonymous peer reviewers.

They are trying to subvert the most basic principal of scientific journals, the peer review process, and making the bogus claim that "Scientific journals such as NEJM may have received manuscripts that contain exonerating data for Celebrex and Bextra which would be relevant for Pfizer's causation defence," for cases involving its Cox-2 inhibitors Celebrex and Bextra.

One hopes that the just slaps them down.

0 comments :

Post a Comment